title: The optimal duration of adjuvant tamoxifen treatment for breast cancer remains uncertain: randomize into aTTom.
authors.forename: H
authors.initials: H
authors.lastname: Earl
authors.forename: R
authors.initials: R
authors.lastname: Gray
authors.forename: D
authors.initials: D
authors.lastname: Kerr
authors.forename: M
authors.initials: M
authors.lastname: Lee
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D012107:Research Design; D013629:Tamoxifen / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen